5
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Improved diagnosis of primary hyperparathyroidism by defining the inverse relationship between serum immunoreactive parathyroid hormone and calcium

, &
Pages 435-442 | Received 12 Jun 1985, Accepted 05 Feb 1986, Published online: 08 Jul 2009

References

  • Sherwood L M, Potts J T, Care A D, Mayer G P, Aurbach G D. Evaluation by radioimmunoassay for factors controlling the secretion of parathyroid hormone. Nature 1966; 209: 52–5
  • Sherwood L M, Herrman I, Bassett C A. Parathyroid hormone secretion in vitro: regulation by calcium and magnesium ions. Nature 1970; 225: 1056–8
  • Brown E M, Brennan M F, Hurwitz S, Windeck R, Marx S J, Spiegel A M, Koehler J O, Gardner D G, Aurbach G D. Dispersed cells prepared from human parathyroid glands: Distinct calcium sensitivity of adenomas vs. primary hyperplasia. J Clin Endocrinol Metab 1978; 46: 267–75
  • Brown E M. Four‐parameter model of the sig‐moidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983; 56: 572–6
  • Brown E M, Gardner D G, Brennan M F, Marx S J, Spiegel A M, Attie M F, Downs R W, Doppman J L, Aurbach G D. Calcium‐regulated parathyroid hormone release in primary hyperparathyroidism. Studies in vitro with dispersed parathyroid cells. Am J Med 1979; 66: 923–31
  • Brown E M, Broadus A E, Brennan M F, Gardner D G, Marx J, Spiegel A M, Downs R W, Jr, Attie M, Aurbch G D. Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism. J Clin Endocrinol Metab 1979; 48: 604–10
  • Habener J F. Responsiveness of neoplastic and hyperplastic parathyroid tissue to calcium in vitro. J Clin Invest 1978; 62: 436–50
  • Reiss E, Canterbury J M. Primary hyperparathyroidism. Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med 1960; 280: 1381–5
  • Reiss E, Canterbury J M. Genesis of hyperparathyroidism. Am J Med 1971; 50: 679–85
  • Sherwood L M, Herrman I, Bassett C A. In vitro studies of normal and abnormal parathyroid tissue. Arch Intern Med 1969; 124: 426–30
  • Sherwood L M, Lundberg W B, Targovnik J H, Rodman J S, Seyfer B S. Synthesis and secretion of parathyroid hormone in vitro. Am J Med 1971; 50: 658–69
  • Birnbaumer M E, Schneider A B, Palmer D, Hanley D A, Sherwood L M. Secretion of parathyroid hormone by abnormal human parathyroid glands in vitro. J Clin Endocrinol Metab 1977; 45: 105–13
  • Dietel M, Dorn G, Montz R, Altenähr E. The effect of calcium and dibutyryl‐cAMP on the secretion of parathyroid hormone by human parathyroid adenomas in organ culture. Acta Endocrinol 1977; 85: 541–7
  • Gautvik K M, Teig V, Halvorsen J F, Arnesen E, Myhre L, Heimann P, Tollman R. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparthyroidism. Scand J Clin Lab Invest 1979; 39: 469–78
  • Fauchald P, Gautvik V T, Gautvik K M. Immunoreactive parathyroid hormone and calcitonin in plasma and ultrafiltrate before and after haemodialysis. Scand J Clin Lab Invest 1985; 45: 229–35
  • Arnaud C D, Tsao H S, Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest 1972; 50: 21–34
  • Bouillon R, DeMoor P. Parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 1977; 45: 261–9
  • Broadus A E, Deftos L J, Banter F C. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: Use as a parathyroid suppression test. J Clin Endocrinol Metab 1978; 46: 477–87
  • Hawker C D. Parathyroid hormone: radioimmunoassay and clinical interpretation. Ann Clin Lab Sci 1975; 5: 383–98
  • Hawker C D, Di Bella F P. Radioimmunoassays for intact and carboxyl‐terminal parathyroid hormone: clinical interpretation and diagnostic signficance. Ann Clin Lab Sci 1980; 10: 76–88
  • Murray T M, Peacock M, Powell D, Monchik J M, Potts J T. Non‐autonomy of hormone secretion in primary hyperparathyroidism. Clin Endocrinol 1972; 1: 235–46
  • Potts J T, Murray T M, Peacock M, Niall H D, Tregear G W, Keutmaan H T, Powell D, Deftos L J. Parathyroid hormone: Sequence, synthesis, immunoassay studies. Am J Med 1971; 50: 639–49
  • Gautvik K M, Gautvik V T, Halvorsen J F. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure. Scand J Clin Lab Invest 1983; 43: 553–64
  • Berson S A, Yalow R S. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocr 1968; 28: 1037–47
  • Freitag J, Martin K J, Hruska K A, Anderson C, Conrades M, Ladenson J, Klahr S, Slatopolsky E. Impaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med 1978; 298: 29–32
  • Hawker C D, Di Bella F P. Parathyroid hormone in chronic renal failure: Studies with two different parathyroid hormone radioimmunoassays. Contrib Nephrol 1980; 20: 21–37
  • Hruska K A, Martin K, Mennes P, Greenwalt C, Anderson S, Klahr S, Slatopolsky E. Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate Ca++ concentrations. J Clin Invest 1977; 60: 501–10
  • Papapoulos S E, Hendy G N, Tomlinson S, Lewin I G, O'Riordan L H. Clearance of exogenous parathyroid hormone in normal and uremic man. Clin Endocrinol 1977; 7: 211–25
  • Yalow R S. Clinical significance of the heterogeneity of parathyroid hormone. Contrib Nephrol 1980; 20: 15–20
  • Gautvik K M, Gordeladze J O, Moxheim E, Gautvik V T. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies. Eur Surg Res 1984; 16(Suppl. 2)41–54
  • Kvarstein B, Gautvik K M, Steinsvik E, Mathisen W. Diagnosis of hyperparathyroidism in patients with urolithiasis using measurement of serum immunoreactive parathyroid hormone and serum calcium. Scand J Urol Nephrol 1983; 17: 105–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.